XML 32 R25.htm IDEA: XBRL DOCUMENT
v3.21.4

RESEARCH AND DEVELOPMENT (Tables) | 12 Months Ended
--- | ---
Sep. 30, 2021
Research And Development [Abstract] |
Disclosure of research and development expenses [Table Text Block] |
| Year ended | Year ended | Period ended
| September 30, 2021 | September 30, 2020 | September 30, 2019
| $ | $ | $
Laboratory costs (see Note 11) | 82,871 | 25,874 | 27,164
Novel drug development | 3,638,910 | 110,029 | -
Patents and related payments | 513,302 | 13,895 | -
Salary and subcontractors | 1,369,769 | 43,754 | 14,845
Share-based compensation (see Note 6) | 709,136 | 161,300 | -
| 6,313,988 | 354,852 | 42,009

X
- Definition Disclosure of detailed information about research and development. + References No definition available. + Details
Name: | drug_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExplanatory
Namespace Prefix: | drug_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | drug_ResearchAndDevelopmentAbstract
Namespace Prefix: | drug_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration